Academic Journal

Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception

التفاصيل البيبلوغرافية
العنوان: Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception
المؤلفون: Sellami, Inès, Barbotin, Anne Laure, Bernard, Valérie, Robin, Geoffroy, Catteau-Jonard, Sophie, Sonigo, Charlotte, Peigné, Maeliss
المصدر: Seminars in Reproductive Medicine ; volume 42, issue 01, page 025-033 ; ISSN 1526-8004 1526-4564
بيانات النشر: Georg Thieme Verlag KG
سنة النشر: 2024
الوصف: In recent years, the prevalence of infertility has increased, and appears to affect approximately one in six couples. Some of them must perform assisted reproductive techniques (ART) in order to achieve pregnancy. As a result, growing interest has arisen about predictive factors of pregnancy and live birth with and without ART. Anti-Mullerian hormone (AMH) is a glycoprotein discovered in the 1950s in male embryonic sexual differentiation. Later, in 1984, its role in folliculogenesis was reported: secreted by granulosa cells, this hormone is involved in the regulation of the recruitment of primordial follicles and in follicular growth. AMH assays were developed for women in 1990s, and the serum AMH level has rapidly become a crucial element in managing women's fertility. Based mainly on its ability to be a quantitative but indirect marker of ovarian reserve, the serum AMH assay is widely used in reproductive medicine and ART. This review summarizes current knowledge of the AMH assessment in the field of reproductive medicine. We focus on the role of AMH level to predict spontaneous pregnancy occurrence, ART outcomes, and fertility preservation outcomes.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1055/s-0044-1787273
DOI: 10.1055/s-0044-1787273.pdf
الاتاحة: http://dx.doi.org/10.1055/s-0044-1787273
http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0044-1787273.pdf
رقم الانضمام: edsbas.18DA6FF4
قاعدة البيانات: BASE